Symbol Name ID |
Cldn16
claudin 16 MGI:2148742 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Cldn16tm1.1Dmu/Cldn16tm1.1Dmu involves: 129 * BALB/cJ * C57BL/6 |
abnormal renal calcium reabsorption | J:159706 |
abnormal renal reabsorption | J:159706 | |
abnormal vitamin D level | J:159706 | |
decreased circulating magnesium level | J:159706 | |
decreased urine pH | J:159706 | |
increased circulating parathyroid hormone level | J:159706 | |
increased urine calcium level | J:159706 | |
Tg(RNU6-RNAi:Cldn16)551Dago/0 involves: C57BL/6 * DBA/2 |
decreased bone mineral content | J:122766 |
decreased bone mineral density | J:122766 | |
decreased circulating magnesium level | J:122766 | |
hypokalemia | J:122766 | |
hypotension | J:122766 | |
increased circulating aldosterone level | J:122766 | |
increased urine calcium level | J:122766 | |
increased urine magnesium level | J:122766 | |
increased urine potassium level | J:122766 | |
nephrocalcinosis | J:122766 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|